Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Bluebird Bio, Inc. (BLUE)  
$0.91 0.04 (4.28%) as of 4:30 Wed 6/26


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 139,126,000
Market Cap: 126.22(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.8537 - $4.83
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   bluebird bio is a company focused on the pursuit of curative gene therapies for severe genetic diseases. Co. has late-stage clinical and research programs for the treatment of sickle cell disease (SCD), ss-thalassemia and cerebral adrenoleukodystrophy and is developing research to apply new technologies to these and other diseases. Using a proprietary lentiviral vector platform, Co. custom designs each of its therapies to address the underlying cause of disease by introducing a functional copy of a gene to patients' own isolated hematopoietic stem cells. Co. is developing lovotibeglogene autotemcel as a one-time treatment for patients with SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 3,834 34,841 57,218 116,663
Total Sell Value $3,726 $44,583 $128,469 $435,194
Total People Sold 1 4 5 9
Total Sell Transactions 1 9 12 23
End Date 2024-03-28 2023-12-26 2023-06-27 2022-06-27

   
Records found: 940
  Page 35 of 38  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-06-10 4 AS $24.23 $145,380 D/D (6,000) 0     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-06-10 4 OE $2.09 $12,540 D/D 6,000 6,000     -
   Leschly Nick President and CEO   •       •      –    2014-06-02 4 AS $22.21 $111,050 D/D (5,000) 415,584     -
   Finer Mitchell H. Chief Scientific Officer   •       –      –    2014-06-02 4 AS $22.21 $177,680 D/D (8,000) 0     -
   Finer Mitchell H. Chief Scientific Officer   •       –      –    2014-06-02 4 OE $0.95 $7,600 D/D 8,000 8,000     -
   Davidson David Chief Medical Officer   •       –      –    2014-06-02 4 AS $22.21 $66,630 D/D (3,000) 0     -
   Davidson David Chief Medical Officer   •       –      –    2014-06-02 4 OE $2.09 $6,270 D/D 3,000 3,000     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-05-14 4 AS $20.03 $30,045 D/D (1,500) 0     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-05-14 4 OE $2.09 $3,135 D/D 1,500 1,500     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-05-12 4 AS $18.93 $85,185 D/D (4,500) 0     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-05-12 4 OE $2.09 $9,405 D/D 4,500 4,500     -
   Leschly Nick President and CEO   •       •      –    2014-05-07 4 OE $2.09 $242,996 D/D 116,266 420,584     -
   Leschly Nick President and CEO   •       •      –    2014-05-01 4 AS $20.07 $100,350 D/D (5,000) 304,318     -
   Davidson David Chief Medical Officer   •       –      –    2014-05-01 4 AS $19.85 $79,400 D/D (4,000) 0     -
   Davidson David Chief Medical Officer   •       –      –    2014-05-01 4 OE $2.09 $8,360 D/D 4,000 4,000     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-04-10 4 AS $21.29 $127,740 D/D (6,000) 0     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-04-10 4 OE $2.09 $12,540 D/D 6,000 6,000     -
   Leschly Nick President and CEO   •       •      –    2014-04-01 4 AS $22.74 $113,700 D/D (5,000) 309,318     -
   Davidson David Chief Medical Officer   •       –      –    2014-04-01 4 AS $22.74 $90,960 D/D (4,000) 0     -
   Davidson David Chief Medical Officer   •       –      –    2014-04-01 4 OE $2.09 $8,360 D/D 4,000 4,000     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-03-10 4 AS $25.80 $154,800 D/D (6,000) 0     -
   Walsh Jeffrey T. Chief Operating Officer   •       –      –    2014-03-10 4 OE $2.09 $12,540 D/D 6,000 6,000     -
   Finer Mitchell H. Chief Scientific Officer   •       –      –    2014-03-03 4 AS $24.79 $198,320 D/D (8,000) 0     -
   Finer Mitchell H. Chief Scientific Officer   •       –      –    2014-03-03 4 OE $0.95 $7,600 D/D 8,000 8,000     -
   Leschly Nick President and CEO   •       •      –    2014-03-03 4 AS $24.79 $123,950 D/D (5,000) 314,318     -
  940 Records found
  Previous  30  31  32  33  34  35  36  37  38   
  Page 35 of 38
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us